Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Celution Prepared Adipose Derived Regenerative Cells in the Treatment of Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT02326961

Public ClinicalTrials.gov record NCT02326961. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Celution Prepared Adipose Derived Regenerative Cells in the Treatment of Osteoarthritis of the Knee: A Double-blind, Placebo Controlled, Multi-center Safety and Feasibility Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the safety and feasibility of intraarticular injection of Celution prepared adipose-derived regenerative cells injected into knees of patients with chronic knee pain due to osteoarthritis.

Study identification

NCT ID
NCT02326961
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cytori Therapeutics
Industry
Enrollment
94 participants

Conditions and interventions

Interventions

Device · Other

Eligibility (public fields only)

Age range
40 Years to 69 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2015 (Type not available)
Primary completion
Jun 2016 (Actual)
Completion
Oct 2016 (Actual)
Last update posted
Oct 28, 2016

2015 – 2016

United States locations

U.S. sites
11
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
Arizona Arthritis and Rheumatology Research, PLLC Mesa Arizona 85202 —
Baptist Health Center for Clinical Research Little Rock Arkansas 72205 —
BioSolutions Clinical Research Center La Mesa California 91942 —
Rush University Medical Center Chicago Illinois 60612 —
Heartland Research Associates Wichita Kansas 67207 —
Central Kentucky Research Associates Lexington Kentucky 40509 —
Covington Orthopedic and Sports Medicine Institute Covington Louisiana 70433 —
Arthritis Treatment Center Frederick Maryland 21702 —
Center for Pharmaceutical Research Kansas City Missouri 64114 —
Hospital for Special Surgery New York New York 10021 —
Altoona Center for Clinical Research Duncansville Pennsylvania 16635 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02326961, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2016 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02326961 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →